(Q51979921)

19 April 2018

title

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. (English)

1 reference

19 April 2018

chronic lymphocytic leukemia

0 references

1 reference

1 reference

B-cell chronic lymphocytic leukemia

inferred from title

1 reference

Hüttmann A

1

1 reference

19 April 2018

Klein-Hitpass L

2

1 reference

19 April 2018

Thomale J

3

1 reference

19 April 2018

Deenen R

4

1 reference

19 April 2018

Carpinteiro A

5

1 reference

19 April 2018

Nückel H

6

1 reference

19 April 2018

Ebeling P

7

1 reference

19 April 2018

Führer A

8

1 reference

19 April 2018

Edelmann J

9

1 reference

19 April 2018

Sellmann L

10

1 reference

19 April 2018

Dührsen U

11

1 reference

19 April 2018

Dürig J

12

1 reference

19 April 2018

publication date

17 August 2006

1 reference

19 April 2018

published in

Leukemia

1 reference

19 April 2018

volume

20

1 reference

19 April 2018

issue

10

1 reference

19 April 2018

page(s)

1774-1782

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404363

exact match

0 references

cites work

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Clinical significance of CD38 expression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

GOstat: find statistically overrepresented Gene Ontologies within a group of genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

FcRH1: an activation coreceptor on human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Molecular cloning and characterization of SPAP1, an inhibitory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Differential expression of CD180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Identification of a family of Fc receptor homologs with preferential B cell expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

The inhibitory potential of Fc receptor homolog 4 on memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

7 January 2021

B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

7 January 2021

The angiogenic status of B-CLL B cells: role of the VEGF receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

7 January 2021

Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404363

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404363

1 reference

19 April 2018

1 reference

19 April 2018